Consensus Conference on the DGVS on Gastroesophageal reflux. Subject group I: Definitions, epidemiology and natural course;Gastroösophageale Refluxkrankheit - Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankhelten: Themenkomplex I: Definitionen, epidemiologie und natürlicher verlauf

Zeitschrift fur Gastroenterologie

Volumn 43, Issue 2, 2005, Pages 165-168

  Schepp, W ^a   Allescher, H D ^a   Frieling, T ^a   Katschinski, M ^a   Malfertheiner, P ^a   Pehl, C ^a   Peitz, U ^a   Rosch W ^a   Hotz, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CHOLINERGIC RECEPTOR BLOCKING AGENT; NITRO DERIVATIVE; ORAL CONTRACEPTIVE AGENT; PSYCHOTROPIC AGENT; THEOPHYLLINE;

CONFERENCE PAPER; CONSENSUS; DISEASE COURSE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HUMAN; INCIDENCE; NOMENCLATURE; PREVALENCE; RISK FACTOR; SOCIOECONOMICS; ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER STAGING; CONSENSUS DEVELOPMENT; CROSS-SECTIONAL STUDY; ESOPHAGUS; ESOPHAGUS TUMOR; FOLLOW UP; GERMANY; PATHOLOGY; PRECANCER; REFLUX ESOPHAGITIS;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CROSS-SECTIONAL STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; ESOPHAGUS; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; GERMANY; HUMANS; INCIDENCE; NEOPLASM STAGING; PRECANCEROUS CONDITIONS;

EID: 14744285000     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-857871     Document Type: Conference Paper

References (65)

1. Dent J, Brun J, Frederick A et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44 (Suppl 2): S1-16
2. Locke GR, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted county, Minnesota. Gastroenterology 1997; 112: 1448-1456
3. Dimenas E, Carlsson G, Glise H et al. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996; 31 (Suppl 221): 8-13
4. McDougall NI, Johnston BT, Kee F et al. Natural history of reflux oesophagitis: a 10 year follow-up of its effect on patient symptomatology and quality of life. Gut 1996; 38: 481-486
5. Quigley EM. Non erosive reflux disease: part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both? Eur J Gastroenterol Hepatol 2001; 13 (Suppl 1): S13-18
6. Kulig M, Leodolter A, Vieth M et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003; 18: 767-776
7. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastrooesophageal reflux disease in an adult population. Ann Med 1995; 27: 67-70
8. Raiha I, Impivaara O, Seppala M et al. Determinants of symptoms suggestive of gastroesophageal reflux disease in the elderly. Scand J Gastroenterol 1993; 28: 1011-1014
9. Louis E, DeLooze D, Deprez P et al. Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol 2002; 14: 279-284
10. Sonnenberg A, Massey BT, Jacobson SJ. Hospital discharges resulting from esophagitis among Medicare beneficiaries. Dig Dis Sci 1994; 39: 183-188
11. Bardhan KD, Royston C, Nayyar AK. Reflux rising! A disease in evolution? Gastroenterology 2000; 118: A 478
12. El-Serag HB, Sonnenberg A. Extraesophageal complications of gastroesophageal reflux disease in US veterans. Gastroenterology 1997; 113: 755-760
13. Trudgill NJ, Kapur KC, Riley SA. Familial clustering of reflux symptoms. Am J Gastroenterology 1999; 94: 1172-1178
14. Lööf L, Gotell P, Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 1993; 28: 113-118
15. Agnew SR, Pandya SP, Reynolds RPE et al. Predictors for frequent esophageal dilations of benign peptic strictures. Dig Dis Sci 1996; 5: 931-936
16. Jornod P, Dorta G, Pantoflickova D et al. Peptic esophageal stricture: a vanishing complication of reflux esophagitis? Gastroenterology 2000; 118: A 484
17. Nayyar AK, Roysten C, Bardhan KD. Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era. Dig Liver Dis 2003; 35: 143-150
18. Kennedy T, Jones R. The prevalence of gastrooesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 1589-1594
19. Ruth M, Mansson I, Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol 1991; 26: 73-81
20. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: Results from the Domestic/ International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999; 231 (Suppl): 20-28
21. Kay L, Jorgensen T, Jensen KH. Epidemiology of abdominal symptoms in a random population: prevalence, incidence, and natural history. Eur J Epidemiol 1994; 10: 559-566
22. Bolin TD, Korman MG, Hansky J et al. Heartburn: community perceptions. J Gastroenterol Hepatol 2000; 15: 35-39
23. Voutilainen M, Sipponen P, Mecklin JP et al. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1.128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000; 61: 6-13
24. Carlsson R, Dent J, Watts R et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1998; 10: 119-124
25. Spechler SJ. Epidemiology and natural history of gastroesophageal reflux disease. Digestion 1992; 51 (suppl 1): 24-29
26. Triadafilopoulos G, Sharma R. Features of symptomatic gastroesophageal reflux disease in elderly patients. Am J Gastroenterol 1997; 92: 2007-2011
27. Rantanen TK, Salo JA. Gastroesophageal reflux disease as a cause of death: analysis of fatal cases under conservative treatment. Scand J Gastroenterol 1999; 34: 229-233
28. Van der Burgh A, Dees J, Hop WCJ et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996; 39: 5-8
29. Panos MZ, Walt RP, Stevenson C et al. Rising death rate from non-malignant disease of the oesophagus (NMOD) in England and Wales. Gut 1995; 36: 488-491
30. Schwenkglenks M, Marbet UA, Szucs TD. Epidemiology and costs of gastroesophageal reflux disease in Swizerland: a population-based study. Soz Präventivmed 2004; 49: 51-61
31. Bloom BS, Jayadevappa R, Wahl P et al. Time trends in cost of caring for people with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96 (suppl): S64-69
32. Wahlquist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol 2001; 96 (Suppl): S57-61
33. Dean BB, Crawley JA, Schmitt CM et al. The burden of illness of gastrooesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther 2003; 17: 1309-1317
34. Henke CJ, Levin TR, Henning JM et al. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 2000; 95: 787-792
35. Glise H. Quality of life and cost of therapy in reflux disease. Scand J Gastroenterol 1995; 30 (suppl 210): 38-42
36. Levin TR, Schmittdiel JA, Kunz K et al. Costs of acid-related disorders to a health maintenance organization. Am J Med 1997; 103: 520-528
37. Pace F, Santalucia F, Bianchi Porro G. Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut 1991; 32: 845-848
38. Aste H, Bonelli L, Ferraris R et al. Gastroesophageal reflux disease. Relationship between clinical and histological features. Dig Dis Sci 1999; 44: 2412-2418
39. Kuster E, Ros E, Toledo-Pimentel V et al. Predictive factors of the long-term outcome in gastro-oesophageal reflux disease: six-year follow-up of 107 patients. Gut 1994; 35: 8-14
40. Olloyo JB, Monnier P, Fontolliet C et al. The natural history, prevalence and incidence of reflux esophagitis. Gullet 1993; 3: 3-10
41. Isolauri J, Luostarinen M, Isolauri E et al. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997; 92: 37-41
42. Schindlbeck NE, Klauser AG, Berghammer G et al. Three year follow up of patients with gastrooesophageal reflux disease. Gut 1992; 33: 1016-1019
43. Robinson N, Lanza F, Avner D et al. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole: a randomized, double-blind, placebo controlled trial. Ann Intern Med 1996; 124: 859-867
44. Vigneri S, Termini R, Leandro G et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995; 333: 1106-1110
45. Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 2003; 32: 235-261
46. Wilmer A, Tack J, Frans E et al. Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology 1999; 116: 1293-1299
47. Miller LS, Vinayek R, Frucht H et al. Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology 1990; 98: 341-346
48. Korsten MA, Rosman AS, Fishbein S et al. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med 1991; 90: 701-706
49. Shoenut JP, Wielers A, Micflikier AB. The extent and pattern of gastrooesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole. Aliment Pharmacol Ther 1993; 7: 509-513
50. Böhmer CJM, Klinkenberg-Knol EC, de Niezen-Boer MC et al. Gastroesopheageal reflux disease in intellectually disabled individuals: how often, how serious, how manageable? Am J Gastroenterol 2000; 95: 1868-1872
51. Fujiwara Y, Nakagawa K, Kusunoki M. Gastroesophageal reflux after distal gastrectomy: possible significance of the angle of His. Am J Gastroenterol 1998; 93: 11-15
52. Rothwell JF, Lawlor P, Byrne PJ. Cholecystectomy-induced gastroesophageal reflux: is it reduced by the laparoscopic approach? Am J Gastroenterol 1997; 92: 1351-1354
53. Cekin AH, Boyacioglu S, Gursoy M et al. Gastroesophageal reflux disease in chronic renal failure patients with upper GI symptoms: multivariate analysis of pathogenetic factors. Am J Gastroenterol 2002; 97: 1352-1356
54. Iovino P, Ciacci C, Sabbatini F et al. Esophageal impairment in adult celiac disease with steatorrhea. Am J Gastroenterol 1998; 93: 1243-1249
55. Lluch I, Ascaso JF, Mora F et al. Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol 1999; 94: 919-924
56. Murray FE, Lombard MG, Ashe J et al. Esophageal function in diabetes mellitus with special reference to acid studies and relationship to peripheral neuropathy. Am J Gastroenterol 1987; 82: 840-843
57. Mehta AJ, de Caestecker JS, Camm AJ et al. Gastro-oesophageal reflux in patients with coronary artery disease: how common is it and does it matter? Eur J Gastroenterol Hepatol 1996; 8: 973-978
58. Avidan B, Sonnenberg A, Giblovich H et al. Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther 2001; 15: 1907-1912
59. Ing AJ, Ngu MC, Breslin AB. Obstructive sleep apnea and gastroesophageal reflux. Am J Med 2000; 108 (Suppl 4a): 120S-125S
60. Rasche K, Sanner B, Schäfer T et al. Sleep, breathing and gastroesophageal reflux. Dtsch Med Wochenschr 1997; 122: 659-663
61. Penzel T, Becker HF, Brandenburg U et al. Arousal in patients with gastro-oesophageal reflux and sleep apnea. Eur Respir J 1999; 14: 1266-1270
62. Lagergren J, Bergstrom R, Adami Ho et al. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 2000; 133: 165-175
63. Achem SR, Kolts BE. Current medical therapy for esophageal motility disorders. Am J Med 1992; 92 (suppl 5A): 98S-105S
64. Helm JF, Dodds WJ, Hogan WJ et al. Acid neutralizing capacity of human saliva. Gastroenterology 1982; 83: 69-74
65. Kim SL, Hunter JG, Wo JM et al. NSAIDs, aspirin, and esophageal strictures: are over-the-counter medications harmful to the esophagus? J Clin Gastroenterol 1999; 29: 32-34